跳至主導覽 跳至搜尋 跳過主要內容

Curcumin-enhanced chemosensitivity of FDA-approved platinum (II)-based anti-cancer drugs involves downregulation of nuclear endonuclease G and NF-κB as well as induction of apoptosis and G2/M arrest

  • Ying Ti Wang
  • , Hsiao Sheng Liu
  • , Chun Li Su*
  • *此作品的通信作者

    研究成果: 雜誌貢獻期刊論文同行評審

    32   連結會在新分頁中打開 引文 斯高帕斯(Scopus)

    指紋

    深入研究「Curcumin-enhanced chemosensitivity of FDA-approved platinum (II)-based anti-cancer drugs involves downregulation of nuclear endonuclease G and NF-κB as well as induction of apoptosis and G2/M arrest」主題。共同形成了獨特的指紋。
    排序方式

    INIS

    Biochemistry, Genetics and Molecular Biology

    Pharmacology, Toxicology and Pharmaceutical Science

    Immunology and Microbiology